Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Second-quarter report 2024

Mixed demand, solid orders, revenues and operating cash flowThe comparison figures presented in this report refer to previous year unless otherwise stated. Second quarter · Orders received reached MSEK 43 654 (43 471), organic decline of 1% · Revenues increased 3% to MSEK 44 803 (43 364), organic growth of 2% · Operating profit reached MSEK 9 466 (9 189), corresponding to a margin of 21.1% (21.2) · Adjusted operating profit, excluding items affecting comparability, was MSEK 9 785 (9 488),corresponding to a margin of 21.8% (21.9) · Profit before tax amounted to MSEK

BioStock: Biosergen on dosing the first patient with life-threatening fungal disease

The first patient has been dosed in Biosergen’s clinical phase Ib trial with BSG005, intended as rescue therapy for invasive fungal infection to increase survival rates for these critically ill patients. Topline results are anticipated by year-end or early 2025. BioStock reached out to CEO Tine Kold Olesen to learn more about the latest achievement.Read the interview at biostock.se:https://www.biostock.se/en/2024/07/biosergen-on-dosing-the-first-patient-with-life-threatening-fungal-disease/This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

LiveCasinoRank Unveils 150 New Live Dealer Game Reviews

Stockholm, Sweden, July 2024 – LiveCasinoRank is a dedicated platform focusing on live dealer games and casino reviews. As part of the broader CasinoRank network, it provides high-quality, diverse content related to the live dealer casino industry. The website’s team is thrilled to announce the publication of 150 new live dealer game reviews, enhancing the player experience by providing in-depth, reliable information on a wide array of games from top software providers.These reviews, meticulously crafted by the LiveCasinoRank workers, offer detailed overviews of each game, including

Form 8.3 - Wood Group (John) Plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   +----------------------------------------------------------+-------------------+|(a) Full name of discloser: |Ninety One UK Ltd |+----------------------------------------------------------+-------------------+|(b) Owner or controller of interests and short positions |  ||disclosed, if different from 1(a):

Gaming Innovation Group to drive Betsson’s Inkabet brand in regulated Peru

Gaming Innovation Group Inc. (GiG) has announced an agreement for the provision of its award winning Platform to power long-term tier 1 partner Betsson’s Peruvian brand Inkabet, as the relationship continues to expand across new regulated markets. Inkabet has now been granted their Peruvian licence, and will start operations later this month.  This agreement further reinforces GiG’s strong relationship with Betsson, with the Inkabet brand migrating onto GiG’s powerful new technology and expanding an alliance that covers live brands in eight markets across Europe and Latin America, with

NCC and Liseberg sign agreement for reconstruction of Oceana

NCC and Liseberg amusement park have signed a partnering agreement for the reconstruction of the Oceana Water World in Gothenburg that was damaged by fire earlier this year. In the first stage, the parties will jointly plan and design the reconstruction. “NCC and Liseberg have maintained a close dialogue since the fire and this is an important step in moving closer to completing the project that we initiated together. There will now follow a number of months when we will jointly plan and design the reconstruction of Oceana,” says Niklas Sparw, Head of NCC Building Sweden.    “

Interim report second quarter and first half of 2024

Second quarter 2024 · Order intake increased by 6% to SEK 8,296 million (7,829). For comparable units, the increase was 1%. · Net sales increased by 5% to SEK 8,491 million (8,100). For comparable units, the increase was 1%. · EBITA increased by 3% to SEK 1,253 million (1,213), corresponding to an EBITA margin of 14.8% (15.0%). · Profit for the quarter increased by 1% to SEK 730 million (724) and earnings per share amounted to SEK 2.00 (1.99). · Cash flow from operating activities amounted to SEK 1,029 million (1,112). CEO’s message Second quarterDemand during the

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 162– 18 JULY 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 96/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Communications & Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Invitation to conference call and webcast presentation of Metsä Board's January–June 2024 results

Metsä Board Corporation Investor News 18 July 2024Metsä Board will publish its half-year financial report for January–June 2024 on Thursday 1 August 2024 at 12:00 noon EEST. The release and related presentation material will be available after publishing on the company's website at https://www.metsagroup.com/metsaboard/investors/. A webcast and a conference call for analysts and investors in English will be held on the same day at 3:00 p.m. EEST. CEO Mika Joukio and CFO Henri Sederholm will present the results. The webcast and conference call can be followed online on the company’s

OrderYOYO A/S publishes Strong H1 performance showing 28% Net Revenue growth and EBITDA of DKK 22.8m; a strong +15% EBITDA margin. Net Revenue and Profitability Guidance for 2024 raised.

Company Announcement No. 75 - 2024 OrderYOYO A/SCopenhagen, July 18, 2024 Highlights Business continues to perform strongly. Highly focused strategy solving digital challenges for our Restaurant Partners continues to reap rewards to the benefit of both our Restaurant Partners and OrderYOYO H1 2024 results show higher growth in ARR and Net Revenue than prior guidance. June 2024 ARR is thus DKK 302m – highest ever realised ARR - corresponding to a growth of 23% compared to June 2023. H1 2024 Net Revenue is DKK 148m corresponding to a growth of 28% compared to H1 2023 Net

KONE to equip 2 Finsbury Avenue dual high-rise towers in the City of London

KONE Corporation, press release, July 18, 2024  KONE Corporation, a global leader in the elevator and escalator industry, has won an order to supply 31 elevators and three escalators for the 2 Finsbury Avenue (2FA) high-rise project at Broadgate – the largest pedestrianized neighborhood in the City of London.    2FA by British Land is an office-led, mixed-use development consisting of the 36-story East Tower and the West Tower at 21-stories, linked by a central 12-story podium. The project will create a new benchmark for highly sustainable workspace in central London with

Electrolux Group divests South African water heater business

Electrolux Group has signed an agreement to divest its water heater business in South Africa under the Kwikot brand for an enterprise value of ZAR 2.4bn (approx. SEK 1.4bn) to Haier Smart Home.The divestment includes the Kwikot brand and the production facilities for water heaters (geysers) located in Johannesburg, and is part of the previously communicated  work to sharpen the Group’s strategic focus by divesting non-core assets. The sale is

Summa Equity through NG Group acquires Fortum Recycling and Waste

FORTUM CORPORATION INSIDE INFORMATION 18 July 2024 AT 9:00 EEST Fortum has today signed an agreement to sell its recycling and waste business to the thematic impact investment firm, Summa Equity through its portfolio company NG Group. The total consideration on a debt- and cash-free basis is approximately EUR 800 million. Based on the balance sheet available at signing, Fortum would record a tax-exempt capital gain of approximately EUR 110 million, however, the final capital gain will depend on the balance sheet value at closing. The gain will be reported as Items Affecting Comparability

Wirtek completes acquisition in Portugal

Company Announcement no. 09/202418 July 2024 This announcement contains inside information  Wirtek has signed a binding contract regarding the acquisition of Pragmasoft LDA , a software solutions company located in Porto, Portugal.   Wirtek has together with its advisers performed a thorough and successful due diligence of Pragmasoft over the last months. The signed contract concludes the acquisition process initially announced on 18 April 2024 (company announcement 06/2024 

Medivir to present updated clinical data for fostrox + Lenvima in HCC at ESMO Conference in September

Stockholm — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, is pleased to announce that updated data from the phase 1b/2a study of fostrox (fostroxacitabine) in combination with Lenvima® (lenvatinib) for the treatment of advanced hepatocellular carcinoma (HCC) has been accepted for presentation at the European Society for Medical Oncology (ESMO) Congress in Barcelona, September 13-17, 2024.   The abstract, titled “Fostrox (fostroxacitabine bralpamide) plus lenvatinib in patients

Diamyd Medical receives second U.S. FDA Fast Track designation for Diamyd® - for the prevention of Type 1 Diabetes

Diamyd Medical announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Diamyd[®] (rhGAD65/alum) to treat Type 1 Diabetes in pediatric patients with Stage 1 or Stage 2 Type 1 Diabetes carrying the genotype HLA DR3-DQ2. Earlier this year, Diamyd[®] received Fast Track designation for the treatment of individuals with Stage 3 Type 1 Diabetes carrying the HLA DR3-DQ2 genotype. The FDA grants Fast Track designation to facilitate the development and expedite the review of medicines to treat serious conditions and fill an unmet medical need. Fast Track

Interim report Q2/2024: Enzymatica builds momentum for expansion

Second quarter January-June · Net sales · Net sales reached SEK 15.8 (21.8)reached SEK 6.4 million.(8.8) · The operating result totaled SEK -31.9 (million. -25.5) million. · The operating · Earnings per share, basic and diluted,result totaled SEK were SEK -0.19 (-0.16).-13.5 (-11.2) · Cash flow from operating activities formillion. the period totaled SEK -26.3 (-21.7) · Earnings per million.share, basic anddiluted, were SEK-0.08 (-0.07). · Cash flow fromoperatingactivities totaledSEK

GiG to drive Betsson’s Inkabet brand in regulated Peru, with platform deal.

Gaming Innovation Group Inc. (GiG) has announced an agreement for the provision of its award winning Platform to power long-term tier 1 partner Betsson’s Peruvian brand Inkabet, as the relationship continues to expand across new regulated markets.GiG to drive Betsson’s Inkabet brand in regulated Peru, with platform deal.     Gaming Innovation Group Inc. (GiG) has announced an agreement for the provision of its award winning Platform to power long-term tier 1 partner Betsson’s Peruvian brand Inkabet, as the relationship continues to expand across new regulated markets.   This

Sivers Semiconductors Announces Q2 Results: Strategic Growth and Key 5G Design Wins, Including a Major Global Company

Kista, Sweden // July 18, 2024 // Sivers Semiconductors AB (STO: SIVE), a leading supplier of integrated chips and modules for advanced communications and sensor solutions for AI Photonics, SATCOM, and 5G/6G, today announced its second-quarter results for the fiscal year 2024. The company demonstrated continued growth, securing significant new orders and improving its financial performance.Financial Highlights: · Q2 2024 revenue of SEK 52,3 million, a 14% increase from SEK 45,8 million in Q2 2023. · Adjusted EBITDA improved by 25% to SEK -12,4 million from SEK -16,6 million in Q2

Enzymatica's Board of Directors updates the financial targets

The Board of Directors of Enzymatica AB (publ) has decided to update the company's financial goals. The background is that the company will likely develop the company's business model, so that in addition to being a producer of consumer products, Enzymatica will also become a supplier of enzyme formulations. The new business model is estimated to yield a higher EBIT margin, but lower net sales compared to the calculations that were the basis for the previous financial targets. In November 2021, Enzymatica's board decided that the company's financial goal would be a net turnover of at

Employee Long Term Incentive Plan and Issue of Equity

18 July 2024   [A close-up of a logo Description automatically generated]          4basebio PLC ("4basebio" or the "Company")   Employee Long Term Incentive Plan and Issue of Equity   Cambridge, UK, 18 July 2024 - 4basebio PLC (AIM: 4BB), an innovation-led provider of novel synthetic DNA products and a non-viral, thermostable nucleic acid delivery platform announces that it has awarded 5,520 ordinary shares of EUR€1.00 each in the Company (“EBT Shares”) to the Employees Benefit Trust (“EBT”), operated by Fiduchi Trustees (UK) Limited at £15.60 per

Notice of Extraordinary General Meeting in Enzymatica AB (publ)

The shareholders in Enzymatica AB (publ), reg. no 556719-9244 (the "Company") are hereby invited to attend the Extraordinary General Meeting ("EGM") to be held on August 6, 2024 at 13:00 CET at Ideon Science Park, Scheelevägen 19 in Lund. Notification etc. Those who wish to participate in the annual general meeting must:   i. be listed as a shareholder in the presentation of the share register prepared by Euroclear Sweden AB concerning the circumstances as per the record date of July 29, 2024; andii. give notice of intent to participate no later than July 31, 2024.

There are no items matching the current filter
There are no more items matching the current filter
Back to top